Walgreens Boots Alliance (NASDAQ:WBA) issued its earnings results on Thursday. The pharmacy operator reported $1.02 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.96 by $0.06, MarketWatch Earnings reports. The company had revenue of $34.75 billion for the quarter, compared to analysts’ expectations of $34.36 billion. Walgreens Boots Alliance had a net margin of 0.55% and a return on equity of 19.43%. Walgreens Boots Alliance’s quarterly revenue was up 2.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.43 EPS.
Shares of WBA opened at $37.41 on Friday. Walgreens Boots Alliance has a 12 month low of $33.88 and a 12 month high of $64.50. The firm’s 50 day moving average is $36.42 and its 200-day moving average is $40.52. The stock has a market capitalization of $32.42 billion, a PE ratio of 45.62, a P/E/G ratio of 1.35 and a beta of 0.43. The company has a current ratio of 0.69, a quick ratio of 0.33 and a debt-to-equity ratio of 0.57.
WBA has been the topic of a number of research analyst reports. Barclays dropped their target price on shares of Walgreens Boots Alliance from $45.00 to $40.00 and set an “equal weight” rating on the stock in a report on Thursday, October 8th. Goldman Sachs Group dropped their target price on shares of Walgreens Boots Alliance from $37.00 to $33.00 and set a “sell” rating on the stock in a report on Tuesday, October 6th. SunTrust Banks lowered their price target on shares of Walgreens Boots Alliance from $42.00 to $40.00 and set a “hold” rating on the stock in a report on Friday, July 10th. Bank of America reissued a “sell” rating and issued a $37.00 price target on shares of Walgreens Boots Alliance in a report on Wednesday, October 7th. Finally, Morgan Stanley lowered their price target on shares of Walgreens Boots Alliance from $45.00 to $40.00 and set an “equal weight” rating on the stock in a report on Thursday, September 3rd. Five investment analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. Walgreens Boots Alliance has a consensus rating of “Hold” and an average price target of $43.19.
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Article: Why is cost of goods sold important?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.